Candidate genes involved in the expression of psychotic symptoms: A focus on hallucinations

The Neuroscience of Hallucinations

Volumn , Issue , 2013, Pages 231-252

  Sanjuán, Julio ^a,b   Moltó, María Dolores ^a,b   Tolosa, Amparo ^b,c  

^a UNIVERSITY OF VALENCIA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893346504     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-4121-2_13     Document Type: Chapter

References (138)

1. Aleman, A., Nieuwenstein, M. R., Booker, K. B., & de Haan, E. H. (1999). Temporal stability of the Launay-Slade Hallucination Scale for high- and low-scoring normal subjects. Psychological Reports,85, 1101-1104.
2. Aleman, A., & Lar0i, F. (2008). Hallucinations: The science of idiosyncratic perception. New York: American Psychological Association.
3. Al-Issa, I. (1995). The illusion of reality or the reality of illusion. Hallucinations and culture. The British Journal of Psychiatry, 166,368-373.
4. Allen, A. J., Griss, M. E., Folley, B. S., et al. (2009). Endophenotypes in schizophrenia: A selective review. Schizophrenia Research, 109,24-37.
5. Allen, P., Lar0i, F., McGuire, P. K., & Aleman, A. (2008). The hallucinating brain: A review of structural and functional neuroimaging studies of hallucinations. Neuroscience and Biobehavioral Reviews, 32,175-191.
6. Angrilli, A., Spironelli, C., Elbert, T., et al. (2009). Schizophrenia as failure of left hemispheric dominance for the phonological component of language. PLoS One,4(2), e4507.
7. Asaad, G., & Shapiro, B. (1986). Hallucinations: Theoretical and clinical overview. The American Journal of Psychiatry, 143,1088-1097.
8. Baiano, M., David, A., Versace, A., et al. (2007). Anterior cingulate volumes in schizophrenia: A systematic review and a meta-analysis of MRI studies. Schizophrenia Research, 93,1-12.
9. Behrendt, R. P. (2006). Dysregulation of thalamic sensory “transmission” in schizophrenia: Neurochemical vulnerability to hallucinations. Journal of Psychopharmacology, 20, 356-372.
10. Behrendt, R. P., & Young, C. (2004). Hallucinations in schizophrenia, sensory impairment, and brain disease: A unifying model. The Behavioral and Brain Sciences, 27,771-787.
11. Bentall, R. P., & Fernyhough, C. (2008). Social predictors of psychotic experiences specificity and psychological mechanisms. Schizophrenia Bulletin, 34, 1012-1020.
12. Bertolino, A., Arciero, G., Rubino, V., et al. (2005). Variation of human amygdala response during threatening stimuli as a function of 5 'HTTLPR genotype and personality style. Biological Psychiatry, 57,1517-1525.
13. Canli, T., Congdon, E., Gutknecht, L., et al. (2005). Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation. Journal of Neural Transmission 112,1479-1485.
14. Cardno, A. G., Sham, P. C., Farmer, A. E., et al. (2002). Heritability of Schneider’s first-rank symptoms. The British Journal of Psychiatry, 180,35-38.
15. Cascella, N. G., Schretlen, D. J., & Sawa, A. (2009). Schizophrenia and epilepsy: Is there a shared susceptibility?Neurosciences Research, 63,227-235.
16. Caspi, A., Hariri, A. R., Holmes, A., et al. (2010). Genetic sensitivity to the environment: The case of the serotonin transporter gene and its implications for studying complex diseases and traits. The American Journal of Psychiatry, 167,509-527.
17. Caspi, A., Moffitt, T. E., Cannon, M., et al. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biological Psychiatry, 57,1117-1127.
18. Caspi, A., Sugden, K., Moffitt, T. E., et al. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science, 301,386-389.
19. Chan, R. C., Li, H., Cheung, E. F., & Gong, Q. Y. (2010). Impaired facial emotion perception in schizophrenia: A meta-analysis. Psychiatry Research, 178,381-390.
20. Chen, E. Y., Wong, G. H., Hui, C. L., et al. (2009). Phenotyping psychosis: Room for neurocomputational and content-dependent cognitive endophenotypes?Cognitive Neuropsychiatry, 14, 451-472.
21. Cohen, A. S., & Minor, K. S. (2010). Emotional experience in patients with schizophrenia revisited: Meta-analysis of laboratory studies. Schizophrenia Bulletin, 36, 143-150.
22. Costas, J., Sanjuan, J., Ramos-Ramos, R., et al. (2011). Interaction between COMT haplotypes and cannabis in schizophrenia: A case-only study in two samples from Spain. Schizophrenia Research, 127,22-27.
23. Crespi, B., Summers, K., & Dorus, S. (2007). Adaptive evolution of genes underlying schizophrenia. Proceedings of the Royal Society B Biological Sciences, 274,2801-2810.
24. Crow, T. J. (2004). Auditory hallucinations as primary disorders of syntax: An evolutionary theory of the origins of language. Cognitive Neuropsychiatry, 9,125-145.
25. Crow, T. J. (2010). A theory of the origin of cerebral asymmetry: Epigenetic variation superimposed on a fixed right-shift. Laterality, 15,289-303.
26. Cuesta, M. J., & Peralta, V. (2008). Current psychopathological issues in psychosis: Towards a phenome-wide scanning approach. Schizophrenia Bulletin, 34,587-590.
27. Cuesta, M. J., & Peralta, V. (2009). Psychopathological assessment of schizophrenia: Relevance for classification. Current Psychiatry Reports, 11,324-331.
28. Diederen, K. M., Neggers, S. F., Daalman, K., et al. (2010). Deactivation of the parahippocampal gyrus preceding auditory hallucinations in schizophrenia. The American Journal of Psychiatry, 167,427-435.
29. Enard, W., Przeworski, M., Fishe, S. E., et al. (2002). Molecular evolution of FOXP2, a gene involved in speech and language. Nature, 418,869-872.
30. Escarti, M. J., de la Iglesia-Vayâ M., Marti-Bonmati, L., et al. (2010). Increased amygdala and parahippocampal gyrus activation in schizophrenic patients with auditory hallucinations: An fMRI study using independent component analysis. Schizophrenia Research, 117,31-41.
31. Ey, H. (1973). Traité des Hallucinations.Paris: Masson.
32. Fantegrossi, W. E., Murnane, K. S., & Reissig, C. J. (2008). The behavioral pharmacology of hallucinogens. Biochemical Pharmacology, 75,17-33.
33. Flint, J., & Munafo, M. R. (2007). The endophenotype concept in psychiatric genetics. Psychological Medicine, 37,163-180.
34. Francks, C., Maegawa, S., Laurén, J., et al. (2007). LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Molecular Psychiatry, 12,1129-1139.
35. Freedman, R., Adler, L. E., Waldo, M. C., et al. (1983). Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: Comparison of medicated and drug-free patients. Biological Psychiatry, 18,537-551.
36. Freeman, D., & Fowler, D. (2009). Routes to psychotic symptoms: Trauma, anxiety and psychosislike experiences. Psychiatry Research, 169,107-112.
37. Freeman, D., & Garety, P. A. (2003). Connecting neurosis and psychosis: The direct influence of emotion on delusions and hallucinations. Behaviour Research and Therapy, 41,923-947.
38. Frith, C. D. (1987). The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action. Psychological Medicine, 17,631-648.
39. Fukata, Y., Adesnik, H., Iwanaga, T., et al. (2006). Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science, 313, 1792-1795.
40. Fuke, S., Suo, S., Takahashi, N., Koike, H., Sasagawa, N., & Ishiura, S. (2001). The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics Journal, 1,152-156.
41. Furmark, T., Tillfors, M., Garpenstrand, H., et al. (2004). Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neuroscience Letters, 362, 189-192.
42. Gelernter, J., Kranzler, H., & Lacobelle, J. (1998). Population studies of polymorphisms at loci of neuropsychiatric interest tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF). Genomics, 52,289-297.
43. Georgieva, L., Dimitrov, A., Niklov, I., et al. (2002). Dopamine transporter gene (DAT1) VNTR polymorphism in major psychiatric disorders: Family-based association study in the Bulgarian population. Acta Psychiatrica Scandinavica, 105,396-399.
44. Goes, F. S., Sanders, L. L., & Potash, J. B. (2008). The genetics of psychotic bipolar disorder. Current Psychiatry Reports,10, 178-189.
45. Goetz, C. G., Burke, P. F., Leurgans, S., et al. (2001). Genetic variation analysis in Parkinson disease patients with and without hallucinations: Case-control study. Archives of Neurology, 58, 209-213.
46. Goldman, J. G., Goetz, C. G., Berry-Kravis, E., et al. (2004). Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: An analysis of the cholecystokinin system. Archives of Neurology, 61,1280-1284.
47. Gottesman, I. I. (1991). Schizophrenia genesis. The origin ofmadness.New York: WH Freeman and Company.
48. Greenberg, B. D., Tolliver, T. J., Huang, S. J., et al. (1999). Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. American Journal of Medical Genetics, 88,83-87.
49. Haddock, G., McCarron, J., Tarrier, N., & Faragher, E. B. (1999). Scales to measure dimensions of hallucinations and delusions: The psychotic symptom rating scales (PSYRATS). Psychological Medicine, 29,879-888.
50. Hamilton, S. P. (2008). Schizophrenia candidate genes: Are we really coming up blank?The American Journal of Psychiatry, 165,420-423.
51. Hariri, A. R., & Holmes, A. (2006). Genetics of emotional regulation: The role of the serotonin transporter in neural function. Trends in Cognitive Sciences, 10,182-191.
52. Hariri, A. R., Mattay, V. S., Tessitore, A., et al. (2002). Serotonin transporter genetic variation and the response of the human amygdala. Science, 297,400-403.
53. Harrison, P. J., & Owen, M. J. (2003). Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet, 36,417-419.
54. Harrison, P. J., & Weinberger, D. R. (2005). Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Molecular Psychiatry, 10,40-68.
55. Heils, A., Teufel, A., Petri, S., et al. (1996). Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry, 66,2621-2624.
56. Henquet, C., Rosa, A., Delespaul, P., et al. (2009). COMT ValMet moderation of cannabis-induced psychosis: A momentary assessment study of ‘switching on’ hallucinations in the flow of daily life. Acta Psychiatrica Scandinavica, 119,156-160.
57. Hoffman, R. E., Hawkins, K. A., Gueorguieva, R., et al. (2003). Transcranial magnetic stimulation of left temporo parietal cortex and medication-resistant auditory hallucinations. Archives of General Psychiatry, 60,49-56.
58. Holden, C. (2003). Neuroscience. Deconstructing schizophrenia. Science, 299, 333-335.
59. Holmes, C., Arranz, M. J., Powell, J. F., et al. (1998). 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer’s disease. Human Molecular Genetics, 7, 1507-1509.
60. Homberg, J. R., Olivier, J. D., Smits, B. M., et al. (2007). Characterization of the serotonin transporter knockout rat: A selective change in the functioning of the serotonergic system. Neuroscience, 146,1662-1676.
61. Howes, O. D., & Kapur, S. (2009). The dopamine hypothesis of schizophrenia: Version III. The final common pathway. Schizophrenia Bulletin, 35,549-562.
62. Ivorra, J. L., Sanjuan, J., Jover, M., et al. (2010). Gene-environment interaction of child temperament. Journal of Developmental and Behavioral Pediatrics, 31,545-554.
63. Jardri, R., Pouchet, A., Pins, D., & Thomas, P. (2011). Cortical activations during auditory verbal hallucinations in schizophrenia: A coordinate-based meta-analysis. The American Journal of Psychiatry, 168,73-81.
64. Jedema, H. P., Gianaros, P. J., Greer, P. J., et al. (2010). Cognitive impact of genetic variation of the serotonin transporter in primates is associated with differences in brain morphology rather than serotonin neurotransmission. Molecular Psychiatry, 15,512-522.
65. Johns, L. C., Allen, P., Valli, I., et al. (2010). Impaired verbal self-monitoring in individuals at high risk of psychosis. Psychological Medicine, 40,1433-1442.
66. Johns, L. C., Hemsley, D., & Kuipers, E. (2002a). A comparison of auditory hallucinations in a psychiatric and non-psychiatric group. The British Journal of Clinical Psychology, 41, 81-86.
67. Johns, L. C., Nazroo, J. Y., Bebbington, P., & Kuipers, E. (2002b). Occurrence of hallucinatory experiences in a community sample and ethnic variations. The British Journal of Psychiatry, 180,174-178.
68. Johns, L. C., & van Os, J. (2001). The continuity of psychotic experiences in the general population. Clinical Psychology Review, 21,1125-1141.
69. Kapur, S., & Mamo, D. (2003). Half a century of antipsychotics and still a central role for dopamine D2 receptors. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 27, 1081-1090.
70. Karg, K., Burmeister, M., Shedden, K., & Sen, S. (2011). The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited. Archives of General Psychiatry, 68,444-454.
71. Khaitovich, P., Hellmann, I., Enard, W., et al. (2005). Parallel patterns of evolution in the genomes and transcriptomes of humans and chimpanzees. Science, 309,1850-1854.
72. Lai, C. S., Fisher, S. E., Hurst, J. A., et al. (2001). A forkhead-domain gene is mutated in a severe speech and language disorder. Nature, 413,519-523.
73. Larkin, W., & Morrison, A. P. (2006). Trauma and psychosis.London: Routledge.
74. Leppanen, J. M., & Nelson, C. A. (2009). Tuning the developing brain to social signals of emotions. Nature Reviews Neuroscience, 10,37-47.
75. Lesch, K. P. (1998). Hallucinations: Psychopathology meets functional genomics. Molecular Psychiatry, 3, 278-281.
76. Lesch, K. P., Bengel, D., Heils, A., et al. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 274,1527-1531.
77. Lesch, K. P., Meyer, J., Glatz, K., et al. (1997). The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: Alternative biallelic variation in rhesus monkeys. Journal of Neural Transmission, 104,1259-1266.
78. Levine, E., Jonas, H., & Serper, M. R. (2004). Interpersonal attributional biases in hallucinatory-prone individuals. Schizophrenia Research, 69,23-28.
79. Limosin, F., Loze, J. Y., Boni, C. L., et al. (2004). The A9 allele of the dopamine transporter gene increases the risk of visual hallucinations during alcohol withdrawal in alcohol-dependent women. Neuroscience Letters, 362,91-94.
80. Lisman, J. E., Pi, H. J., Zhang, Y., & Otmakhova, N. A. (2010). A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia. Biological Psychiatry, 68,17-24.
81. Llinás, R. R., & Paré, D. (1991). Of dreaming and wakefulness. Neuroscience, 44,521-535.
82. Loftus, J., Delisi, L. E., & Crow, T. J. (2000). Factor structure and familiality of first-rank symptoms in sibling pairs with schizophrenia and schizoaffective disorder. The British Journal of Psychiatry, 177,5-19.
83. López-Gil, X., Artigas, F., & Adell, A. (2010). Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex. Current Pharmaceutical Design, 16,502-515.
84. Malhotra, A. K., Goldman, D., Mazzanti, C., et al. (1998). A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Molecular Psychiatry, 3, 328-332.
85. Martí-Bonmatí, L., Lull, J. J., García-Martí, G., et al. (2007). Chronic auditory hallucinations in schizophrenic patients: MR analysis of the coincidence between functional and morphologic abnormalities. Radiology, 244, 549-556.
86. Martin, L. F., & Freedman, R. (2007). Schizophrenia and the alpha7 nicotinic acetylcholine receptor. International Review of Neurobiology, 78,225-246.
87. Martínez-Granados, B., Brotons, O., Martinez-Bisbal, M. C., et al. (2008). Spectroscopic metabo-lomic abnormalities in the thalamus related to auditory hallucinations in patients with schizophrenia. Schizophrenia Research, 104,13-22.
88. McGrath, J. A., Avramopoulos, D., Lasseter, V. K., et al. (2009). Familiarity of novel factorial dimensions of schizophrenia. Archives of General Psychiatry, 66, 591-600.
89. McGuffin, P., Farmer, A. E., Gottesman, I. I., et al. (1984). Twin concordance for operationally defined schizophrenia. Confirmation of familiarity and heritability. Archives of General Psychiatry, 41,541-545.
90. Mulert, C., Kirsch, V., Pascual-Marqui, R., et al. (2011). Long-range synchrony of gamma oscillations and auditory hallucination symptoms in schizophrenia. International Journal of Psychophysiology, 79,55-63.
91. Murphy, D. L., & Lesch, K. P. (2008). Targeting the murine serotonin transporter: Insights into human neurobiology. Nature Reviews Neuroscience, 9, 85-96.
92. Newbury, D. F., & Monaco, A. P. (2001). Genetic advances in the study of speech and language disorders. Neuron, 68,309-320.
93. Nobile, C., Michelucci, R., Andreazza, S., et al. (2009). LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy. Human Mutation, 30,530-536.
94. O’Donovan, M. C., Craddock, N. J., & Owen, M. J. (2009). Genetics of psychosis; insights from views across the genome. Human Genetics, 126,3-12.
95. Okubo, T., & Harada, S. (2001). Polymorphisms of the CCK, CCKAR and CCKBR genes: An association with alcoholism study. Journal of Studies on Alcohol, 62,413-421.
96. Ottman, R., Winawer, M. R., Kalachikov, S., et al. (1995). Partial epilepsy to chromosome 10q. Nature Genetics, 10,56-60.
97. Pezawas, L., Meyer-Lindenberg, A., Drabant, E. M., et al. (2005). 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: A genetic susceptibility mechanism for depression. Nature Neuroscience, 8, 828-834.
98. Preston, G. A., & Weinberger, D. R. (2005). Intermediate phenotypes in schizophrenia: A selective review. Dialogues in Clinical Neuroscience,7, 165-179.
99. Rao, H., Gillihan, S. J., & Wang, J. (2007). Genetic variation in serotonin transporter alters resting brain function in healthy individuals. Biological Psychiatry, 62,600-606.
100. Read, J., Bentall, R. P., & Fosse, R. (2009). Time to abandon the bio-bio-bio model of psychosis: Exploring the epigenetic and psychological mechanisms by which adverse life events lead to psychotic symptoms. Epidemiologia e Psichiatria Sociale, 18,299-310.
101. Rivero, O., Sanjuan, J., Aguilar, E. J., et al. (2010). Serotonin transporter gene polymorphisms and auditory hallucinations in psychosis. Revue Neurologique, 50,325-332.
102. Rivero, O., Sanjuan, J., Moltó, M. D., et al. (2006). The microcephaly ASPM gene and schizophrenia: A preliminary study. Schizophrenia Research, 84,427-429.
103. Rosenthal, D., & Quinn, O. W. (1977). Quadruplet hallucinations. Phenotypic variations of a schizophrenic genotype. Archives of General Psychiatry, 34,817-827.
104. Rossell, S. L., & Boundy, C. L. (2005). Are auditory-verbal hallucinations associated with auditory affective processing deficits?Schizophrenia Research, 78,95-106.
105. Sanjuán, J., Aguilar, E. J., & Artigas, F. (2010). Pharmacological treatment of hallucinations. In A. Aleman & F. Lar0i (Eds.), Treatment of hallucinations.Oxford: Oxford University Press.
106. Sanjuán, J., Aguilar, E. J., & de Frutos, R. (2006a). Time for a broad phenotype in schizophrenia?The British Journal of Psychiatry, 188,190.
107. Sanjuán, J., Gonzalez, J. C., Aguilar, E. J., et al. (2004a). Pleasurable auditory hallucinations. Acta Psychiatrica Scandinavica, 110, 273-278.
108. Sanjuán, J., Lull, J. J., Aguilar, E. J., et al. (2007a). Emotional words induce enhanced brain activity in schizophrenic patients with auditory hallucinations. Psychiatry Research, 154,21-29.
109. Sanjuán, J., Lull, J. J., Martí-Bonmati, L., et al. (2005a). Emotional auditory paradigm in neuroimaging: A base for the study of psychosis. Actas Españolas de Psiquiatría, 33, 383-389.
110. Sanjuán, J., Lull, J. J., Rivero, O., et al. (2007b). Serotonin transporter genetic variation modulates amygdale reactivity to emotional stimuli in patients with schizophrenia. Shizophrenia Bulletin, 33, 383.
111. Sanjuán, J., Rivero, O., Aguilar, E. J., et al. (2006b). Serotonin transporter gene polymorphism (5-HTTLPR) and emotional response to auditory hallucinations in schizophrenia. The International Journal of Neuropsychopharmacology, 9, 131-133.
112. Sanjuán, J., Toirac, I., González, J. C., et al. (2004b). A possible association between the CCK-AR gene and persistent auditory hallucinations in schizophrenia. European Psychiatry, 19, 349-353.
113. Sanjuán, J., Tolosa, A., González, C., et al. (2005b). FOXP2 polymorphisms in patients with schizophrenia. Schizophrenia Research, 73,253-256.
114. Sanjuán, J., Tolosa, A., González, J. C., et al. (2006c). Association between FOXP2 polymorphisms and schizophrenia with auditory hallucinations. Psychiatric Genetics, 16,67-72.
115. Sharp, F. R., Tomitaka, M., Bernaudin, M., & Tomitaka, S. (2001). Psychosis: Pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?Trends in Neurosciences, 24,330-334.
116. Smith, B., Fowler, D. G., Freeman, D., et al. (2006). Emotion and psychosis: Links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations. Schizophrenia Research, 86,181-188.
117. Sommer, I., Aleman, A., Ramsey, N., et al. (2001). Handedness, language lateralisation and anatomical asymmetry in schizophrenia. Meta-analysis. The British Journal of Psychiatry, 178, 344-351.
118. Sommer, I. E., Daalman, K., Rietkerk, T., et al. (2010). Healthy individuals with auditory verbal hallucinations; who are they? Psychiatric assessments of a selected sample of 103 subjects. Schizophrenia Bulletin, 36,633-641.
119. Spencer, K. M., Niznikiewicz, M. A., Nestor, P. G., et al. (2009). Left auditory cortex gamma synchronization and auditory hallucination symptoms in schizophrenia. BMC Neuroscience, 10,85.
120. Spinelli, S., Schwandt, M. L., Lindell, S. G., et al. (2007). Association between the recombinant human serotonin transporter linked promoter region polymorphism and behavior in rhesus macaques during a separation paradigm.Development and Psychopathology, 19,977-987.
121. Spiteri, E., Konopka, G., Coppola, G., et al. (2007). Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain. The American Journal of Human Genetics, 81,1144-1157.
122. Stephane, M., Thuras, P., Nasrallah, H., & Georgopoulos, A. P. (2003). The internal structure of the phenomenology of auditory verbal hallucinations. Schizophrenia Research, 61,185-193.
123. Tachikawa, H., Harada, S., Kawanishi, Y., Okubo, T., & Suzuki, T. (2001). Linked polymorphisms (-333 G > T and -286A > G) in the promoter region of the CCK-A receptor gene may be associated with schizophrenia. Psychiatry Research, 103,147-155.
124. Toirac, I., Sanjuán, J., Aguilar, E. J., et al. (2007). Association between CCK-AR gene and schizophrenia with auditory hallucinations. Psychiatric Genetics, 17,47-53.
125. Tolosa, A., Sanjuán, J., Dagnall, A. M., et al. (2010). FOXP2 gene and language impairment in schizophrenia: Association and epigenetic studies. BMC Medical Genetics, 11,114.
126. Tolosa, A., Sanjuán, J., Leal, C., et al. (2008). Rapid evolving RNA gene HAR1A and schizophrenia. Schizophrenia Research, 99, 370-372.
127. Tost, H., Alam, T., & Meyer-Lindenberg, A. (2010). Dopamine and psychosis: Theory, path-omechanisms and intermediate phenotypes. Neuroscience and Biobehavioral Reviews, 34, 689-700.
128. Turkington, D., Kingdon, D., & Weiden, P. J. (2006). Cognitive behavior therapy for schizophrenia. The American Journal of Psychiatry, 163,365-373.
129. van Os, J., & Kapur, S. (2009). Schizophrenia. Lancet, 374,635-645.
130. van Os, J., Kenis, G., & Rutten, B. P. (2010). The environment and schizophrenia. Nature, 468, 203-212.
131. Vernes, S. C., Spiteri, E., Nicod, J., et al. (2007). High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders. The American Journal of Human Genetics, 81,1232-1250.
132. Vilella, E., Costas, J., Sanjuán, J., et al. (2008). Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4nor their genetic interaction. Journal of Psychiatric Research, 42, 278-288.
133. Walterfang, M., Mocellin, R., Copolov, D., & Velakoulis, D. (2010). Secondary hallucinations. In P. S. Sachdev & M. S. Keshavan (Eds.), Secondary schizophrenia.Cambridge: Cambridge University Press.
134. Wang, J., Zhao, C., & Chen, B. (2004). Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson’s disease. Neuroscience Letters, 355,193-196.
135. Wei, J., & Hemmings, G. P. (1999). The CCK-A receptor gene possibly associated with auditory hallucinations in schizophrenia. European Psychiatry, 14,67-70.
136. Williamson, P. (2006). Mind, Brain, and Schizophrenia.Oxford: Oxford University Press.
137. Zhang, J., Webb, D. M., & Podlaha, O. (2002). Accelerated protein evolution and origins of human-specific features: Foxp2 as an example. Genetics, 162,1825-1835.
138. Zhang, X. Y., Zhou, D. F., Zhang, P. Y., & Wei, J. (2000). The CCK-A receptor gene possibly associated with positive symptoms of schizophrenia. Molecular Psychiatry, 5,239-240.